ADGRA1

Chr 10

adhesion G protein-coupled receptor A1

Also known as: GPR123

This gene encodes an adhesion G-protein-coupled receptor that functions as an orphan receptor, with related proteins in the family regulating sensory systems, blood pressure, immune responses, and development. Mutations in ADGRA1 cause autosomal recessive bilateral frontoparietal polymicrogyria, a cortical malformation disorder affecting brain development. The gene shows minimal constraint against loss-of-function variants, consistent with recessive inheritance requiring biallelic mutations to cause disease.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
98
P/LP submissions
0%
P/LP missense
0.71
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryADGRA1
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
98 unique Pathogenic / Likely Pathogenic· 126 VUS of 236 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.71LOEUF
pLI 0.014
Z-score 2.41
OE 0.36 (0.200.71)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.34Z-score
OE missense 0.80 (0.730.88)
292 obs / 363.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.36 (0.200.71)
00.351.4
Missense OE0.80 (0.730.88)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 6 / 16.6Missense obs/exp: 292 / 363.8Syn Z: 0.69
DN
0.77top 25%
GOF
0.81top 10%
LOF
0.3843th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

236 submitted variants in ClinVar

Classification Summary

Pathogenic93
Likely Pathogenic5
VUS126
Likely Benign8
Benign1
93
Pathogenic
5
Likely Pathogenic
126
VUS
8
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
93
0
93
Likely Pathogenic
0
0
5
0
5
VUS
0
109
17
0
126
Likely Benign
0
5
2
1
8
Benign
0
1
0
0
1
Total01151171233

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ADGRA1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 3 results · since 2015Search PubMed ↗